RARG and ovarian cancer: Furthermore, in order to clarify the promoting effect of RARG on ovarian cancer cells in vivo, we used sh-RARG group (n=5) and sh-Scramble group (n=5) of A2780 cells to inoculate nude mice subcutaneously.